Cytokinetics
(CYTK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | AZN | AMGN | GILD | BMY |
| Company | Cytokinetics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 65.25 | 200.08 | 365.14 | 148.90 | 60.60 |
| High | 66.98 | 204.92 | 368.51 | 157.29 | 61.08 |
| Low | 63.53 | 199.19 | 361.00 | 147.38 | 59.66 |
| Latest | 66.80 | 204.76 | 366.58 | 155.80 | 59.93 |
| Change | +1.95 | +11.36 | +1.93 | +8.57 | -0.93 |
| % Change | +3.01% | +5.87% | +0.53% | +5.82% | -1.53% |
| Volume | 1,952,800 | 3,484,000 | 2,826,100 | 11,433,899 | 11,866,900 |
| 20-Day Average Volume | 1,611,110 | 4,677,178 | 3,198,135 | 8,657,640 | 13,695,910 |
| Previous Close | 64.85 | 193.40 | 364.65 | 147.23 | 60.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 63.90 | 188.15 | 349.63 | 138.98 | 56.69 |
| 20-Day Raw Stochastic | 95.81% | 99.40% | 70.76% | 95.90% | 75.07% |
| 20-Day Relative Strength | 55.94 | 65.16 | 60.61 | 73.11 | 64.45 |
| Weighted Alpha | +29.61 | +48.35 | +32.40 | +60.88 | +22.05 |
| Today's Opinion | 96% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.16% since 02/04/26 | +9.23% since 02/04/26 | +0.10% since 02/04/26 | +6.54% since 02/04/26 | +4.01% since 02/04/26 |
| Low | 60.05 on 02/05/26 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 145.87 on 02/05/26 | 58.00 on 02/05/26 |
| High | 66.98 on 02/11/26 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +6.86% since 01/09/26 | +8.17% since 01/09/26 | +12.41% since 01/09/26 | +28.65% since 01/09/26 | +7.29% since 01/09/26 |
| Low | 60.05 on 02/05/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 67.10 on 02/03/26 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +0.45% since 11/11/25 | +14.92% since 11/11/25 | +8.31% since 11/11/25 | +27.12% since 11/11/25 | +23.01% since 11/11/25 |
| Low | 58.85 on 01/05/26 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 70.98 on 12/22/25 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +101.02% since 08/11/25 | +38.22% since 08/11/25 | +28.58% since 08/11/25 | +29.33% since 08/11/25 | +30.48% since 08/11/25 |
| Low | 33.17 on 08/12/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 70.98 on 12/22/25 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,167,302 | 317,563,904 | 197,396,352 | 193,297,952 | 122,002,680 |
| Shares Outstanding, K | 122,265 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 18,470,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -589,530,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,940,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -306,180,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 0.54 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.54 on 11/05/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/26/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 23.88 | 16.69 | 18.07 | 9.90 |